Equities research analysts at StockNews.com initiated coverage on shares of LiqTech International (NASDAQ:LIQT – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock.
Several other equities research analysts have also recently issued reports on LIQT. Lake Street Capital lowered their target price on shares of LiqTech International from $9.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. Ascendiant Capital Markets decreased their price target on shares of LiqTech International from $5.15 to $3.20 and set a “buy” rating on the stock in a research note on Monday.
View Our Latest Research Report on LIQT
LiqTech International Trading Up 6.0 %
Hedge Funds Weigh In On LiqTech International
A hedge fund recently raised its stake in LiqTech International stock. HighTower Advisors LLC lifted its stake in shares of LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,599 shares of the company’s stock after acquiring an additional 11,043 shares during the period. HighTower Advisors LLC owned 0.66% of LiqTech International worth $99,000 as of its most recent filing with the Securities & Exchange Commission. 35.06% of the stock is owned by institutional investors.
LiqTech International Company Profile
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Recommended Stories
- Five stocks we like better than LiqTech International
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What does consumer price index measure?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.